Is Ketamine Therapy Legal? Europe in 2026

"Is ketamine therapy legal?" is usually asked with an anxious subtext — whether the clinic advertising infusions in your city is operating in a grey zone. In almost every European country the answer is straightforward: it is lawful, it has been lawful for years, and the legal basis is unglamorous. What is genuinely complicated is everything downstream of legality: whether a clinic near you exists, whether anyone will fund it, and how you tell a well-run service from a badly run one.

TL;DR Racemic ketamine is a licensed anaesthetic in every European country. Prescribing it off-label for depression is legal when a licensed physician does so after proper screening. Esketamine (Spravato) is separately approved EU-wide for treatment-resistant depression and publicly reimbursed in most of continental Europe and in Scotland — but not in England and Wales, where NICE did not recommend it. Private ketamine clinics legally operate in the UK, Germany, Switzerland, Spain, Poland, Czechia and Sweden; France restricts the treatment to hospitals. Psilocybin and MDMA are a different legal world entirely.

Why it is legal: the off-label rule

Ketamine has been a licensed anaesthetic since the 1970s and is on the WHO list of essential medicines. It has never been approved as an antidepressant, so treating depression with it is off-label — the indication is not in the marketing authorisation. Off-label prescribing by a licensed physician is lawful throughout Europe; it is ordinary medical practice, used across medicine wherever evidence runs ahead of licensing.

Two consequences follow. First, the treatment is legal but usually unfunded: public systems generally pay for licensed indications, so ketamine infusions are self-pay almost everywhere. Second, there is no dedicated regulatory regime for it. As our clinic-choice guide puts it, there is no European "ketamine clinic" licence — only ordinary healthcare regulation, which is why the verification burden lands on the patient.

Where private clinics actually operate

Legality is uniform; markets are not. Across Europe, private ketamine and ketamine-assisted psychotherapy clinics have grown up where the public route is closed or narrow:

United Kingdom — the most developed private market, with CQC-registered clinics in England and roughly £300–800 per infusion (ketamine therapy in the UK, NHS vs private comparison, Scotland);
Germany — private practices in most large cities at roughly €200–400 per infusion (Germany guide);
Switzerland — legal off-label infusions around CHF 300–500, self-pay (Switzerland guide);
Spain — private clinics in Barcelona, Madrid and Mallorca, with full KAP programmes running into the thousands (Spain guide);
Poland — private clinics in Warsaw, Wrocław and other large cities, self-pay (Poland guide);
Czechia — Prague's Psyon clinic offers ketamine-assisted psychotherapy with partial coverage from seven insurers, as far as we know the only insurer-supported KAP in Europe (Czechia guide);
Sweden — private clinics exist, with the only published tariff we have found at 2,089–6,269 SEK per session (Sweden guide).

Two countries break the pattern in opposite directions. France is legal in principle but effectively has no private market: ketamine for depression is hospital-only, with a March 2026 compassionate framework for suicidal crisis (France guide). Norway went the other way and became the first country to publicly fund generic intravenous ketamine for treatment-resistant depression, delivered in hospitals and district psychiatric centres rather than through a clinic market (Norway guide).

Esketamine is a separate legal question

Spravato — esketamine nasal spray — is not off-label anything. It holds an EU-wide marketing authorisation for treatment-resistant depression, taken alongside a continuing oral antidepressant, and is administered under supervision with an observation period afterwards. Because it is licensed, public systems can and mostly do pay for it: Germany, the Netherlands, Poland, Switzerland, Belgium, Italy, Ireland, Spain, Finland, Czechia, Portugal, Denmark and Scotland all fund it under treatment-resistance criteria. England and Wales are the notable exception, where NICE did not recommend it (TA854) and the route is effectively closed. The full criteria, country by country, are in our reimbursement map and the availability guide.

So "is ketamine therapy legal?" often resolves into a better question: which of the two products is open to you, on what terms. If you can document two adequate failed antidepressant courses — three in Spain, the Netherlands and Finland — a publicly funded esketamine route probably exists in your own country, and it is almost always easier than paying for infusions.

What "legal" does not cover

Legal prescribing says nothing about the quality of the clinic doing the prescribing, and this is the market's weak point. What is actually regulated is the doctor and the facility, through national registers: the Care Quality Commission for independent clinics in England (with Scottish and Welsh equivalents), a physician's Approbation and regional Ärztekammer registration in Germany, the BIG register in the Netherlands, cantonal authorisation via MedReg in Switzerland, and the national physician chamber elsewhere. Verify the doctor first, the facility second.

Three limits are worth knowing:

Take-home and remote-only programmes. Ketamine without in-person supervision carries meaningful safety and dependence risks, and is restricted or prohibited in most European countries. Treat any remote-only offering with caution.

Repeated use is a medical decision, not a subscription. Bladder and urinary-tract damage (ketamine uropathy) and dependence are documented risks of repeated exposure, which is why ongoing treatment belongs in a monitored setting with urinary symptoms tracked over time (ketamine evidence review).

Other compounds are not covered by any of this. Psilocybin and MDMA are controlled substances with no general medical route in Europe: outside clinical trials, lawful psilocybin treatment exists in Switzerland, at Germany's two compassionate-use sites, and under Czechia's framework, and lawful MDMA therapy in Switzerland only. Anyone selling psilocybin or MDMA "therapy" elsewhere in Europe is operating outside the law, whatever the setting looks like. On why ketamine sits in a different legal category despite being discussed alongside them, see is ketamine a psychedelic?.

How to check your own situation

Start with your country's access guide in the access-by-country index, then confirm the provider on the national register before paying anything. Our eligibility check gives an early sense of which route may be open where you live — it runs in your browser and stores nothing — and the directory lists the ketamine and KAP clinics we have verified. If the route you want is closed, clinical trials are free by definition and legal everywhere.

Frequently asked questions

Is ketamine therapy legal in the UK?

Yes. Ketamine is a Schedule 2 medicine, off-label prescribing by a licensed doctor is lawful, and independent clinics must be registered with the CQC in England or the Scottish and Welsh equivalents. Check the CQC profile and rating and the prescriber's GMC number before paying. NHS-funded ketamine exists only narrowly — see our NHS vs private guide.

Is ketamine therapy legal in Germany?

Yes. Racemic ketamine is a licensed anaesthetic and doctors may prescribe it off-label for depression, which is the legal basis of Germany's private infusion and KAP market at roughly €200–400 per session. Note that the German national depression guideline takes a conservative view of off-label ketamine and places it in the inpatient psychiatric setting (Germany guide).

Does legal mean my insurer will pay?

Usually not for racemic ketamine. Off-label status is precisely why public systems rarely reimburse it; the exceptions are Norway, which funds generic IV ketamine publicly, and Czechia, where insurers cover part of ketamine-assisted psychotherapy at one clinic. Esketamine is the reimbursed route in most of Europe.

Do I need a referral, or can I book directly?

It depends on the country and the clinic. Many private clinics accept self-referral after their own medical screening; reimbursed esketamine routes run through a psychiatrist. Whichever door you use, bring a written treatment history: every antidepressant tried in the current episode, with dose, duration and outcome.

Is at-home or online ketamine legal in Europe?

It is restricted or prohibited in most European countries, and where something like it is offered, the safety and dependence concerns are real. Ketamine is not take-home treatment in the European model — dosing happens under supervision with monitoring and a recovery period.

Sources

This guide is for general information only and is not medical advice, a diagnosis, or a recommendation of any treatment. Laws, prices and reimbursement rules change; always verify a provider's current registration with the national regulator and discuss your options with a licensed clinician who knows your history. If you are in crisis, contact your local emergency number or a crisis line immediately.

This guide awaits review by a licensed medical professional.

Is Ketamine Therapy Legal? The European Picture in 2026

On this page